EYPT:NASDAQ
EyePoint Inc
3,25 USD
arrow_upward
+0,62%(+0,020) 1D
3,26 USD
arrow_upward
+0,31% (+0,0100)bedtimeAfter hours
Closed: 2-окт., 16:00:01 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EYPT...
Open
3,31 USD
High
3,31 USD
Low
3,10 USD
Mkt. cap
280,19 млн
Avg. vol.
3,95 млн
Volume
3,11 млн
52-wk high
19,01 USD
52-wk low
3,10 USD
EPS
-3,74 USD
Beta
1,67
Shares outstanding
86,21 млн
No. of employees
214
Open
3,31 USD
High
3,31 USD
Low
3,10 USD
Mkt. cap
280,19 млн
Avg. vol.
3,95 млн
Volume
3,11 млн
52-wk high
19,01 USD
52-wk low
3,10 USD
EPS
-3,74 USD
Beta
1,67
Shares outstanding
86,21 млн
No. of employees
214
News stories
From web sources and news partners
MarketBeat
·
8 мүнөт мурун
Xometry (NASDAQ:XMTR) CEO Sanjeev Singh Sahni Sells 1,112 Shares of Stock
Simply Wall Street
·
54 мүнөт мурун
Ionis Pharmaceuticals Fell 45% With The Case Still Split
Moomoo
·
1 саат мурун
Chip-Led Rally Lifts Nasdaq; Tesla Jumps 4.65%
Profile
EyePoint Pharmaceuticals Inc. is a Watertown, Massachusetts company specialising in the application of microelectromechanical systems and nanotechnology to drug delivery.
pSivida obtained porous silicon technology from the British government Defence Evaluation and Research Agency. QinetiQ continues to be a strategic partner.
In June 2004, pSivida acquired full ownership of pSiMedica. In April 2018, pSivida purchased eye products firm Icon Bioscience. Afterwards, it rebranded to its current name of EyepOint Pharmaceuticals, Inc. Wikipedia
About EyePoint Inc
CEO-
Employees214
Founded2000
HeadquartersУотертаун, Массачусетс, Америка Кошмо Штаттары
SectorPharmaceutical industry
Websiteeyepoint.bio